Sunday, November 28, 2021

FDA News

FDA and CDC Use Technological Advancements to Investigate Multistate Outbreak of Cyclospora Illnesses Linked to Bagged Salads

Today, the U.S. Food and Drug Administration (FDA) is providing an update on the status of the investigation of Cyclospora cayetanensis illnesses tied to the consumption...

FDA Approves Treatment for Rare Disease Affecting Optic Nerves, Spinal Cord

The U.S. Food and Drug Administration has approved Enspryng (satralizumab-mwge) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults with a particular...

FDA’s emergency approval of blood plasma as COVID-19 treatment on hold: NYT

(Reuters) - The emergency approval of blood plasma as a potential COVID-19 treatment by the U.S. Food and Drug Administration has now been put...

U.S. FDA rejects BioMarin hemophilia A gene therapy, shares dive

By Caroline Humer (Reuters) - The U.S. Food and Drug Administration rejected BioMarin Pharmaceutical Inc's gene therapy for bleeding disorder hemophilia A citing the need...

Gilead shares slide after FDA knocks back rheumatoid arthritis drug

(Reuters) - Shares of Gilead Sciences <GILD.O> fell 3% after...

Yale’s COVID-19 saliva test used in NBA gets FDA OK for emergency use

(Reuters) - The U.S. Food and Drug Administration on Saturday...

Report: FDA approves use of NBA-funded COVID-19 test

A COVID-19 test funded by the NBA and the National...

FDA Warns Companies Illegally Selling Hangover Remedies

Today, the U.S. Food and Drug Administration announced it has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that...

FDA Announces Voluntary Agreement with Manufacturers to Phase Out Certain Short-Chain PFAS Used in Food Packaging

Today, the U.S. Food and Drug Administration is announcing that the manufacturers of certain per- and polyfluoroalkyl substances (PFAS) used for grease-proofing in paper and paperboard for food...

FDA authorizes remdesivir as emergency treatment for COVID-19

The U.S. Food and Drug Administration has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat...

Latest News